1-13 of 13
Anthony C Shelton, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed By Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-up Analysis

Vishal K Gupta, MD, Dina Brauneis, NP, Anthony C Shelton, RN, Karen Quillen, MD MPH, John Mark Sloan, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4616.
https://doi.org/10.1182/blood-2018-99-111551
Published: 2018
Journal Articles

Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study

Vaishali Sanchorawala, MD, Shayna Sarosiek, MD, John Mark Sloan, MD, Dina Brauneis, NP, Mary Ellen Migre, Meredith Mistark, Stephanie Santos, Ramon Cruz, Salli Fennessey, Anthony C Shelton, RN
Journal: Blood
Blood (2018) 132 (Supplement 1): 2005.
https://doi.org/10.1182/blood-2018-99-112991
Published: 2018
Journal Articles

Brachial Plexopathy Following High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation for AL Amyloidosis

Vina Nguyen, MD, Dina Brauneis, NP, John Mark Sloan, MD, Shayna Sarosiek, MD, Karen Quillen, MD, Anthony C Shelton, RN, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5509.
https://doi.org/10.1182/blood.V130.Suppl_1.5509.5509
Published: 2017
Journal Articles

Safety and Tolerability of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Preliminary Results of a Phase II Study

Vaishali Sanchorawala, MD, Shayna Sarosiek, MD, John Mark Sloan, MD, Dina Brauneis, NP, Mary Ellen Migre, Meredith Mistark, Stephanie Santos, Salli Fennessey, Anthony C Shelton, RN
Journal: Blood
Blood (2017) 130 (Supplement 1): 507.
https://doi.org/10.1182/blood.V130.Suppl_1.507.507
Published: 2017
Journal Articles

Pomalidomide and Dexamethasone in Patients with Relapsed AL (Light Chain) Amyloidosis: Results of a Phase 1 Study

Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Stephen Lo, John Mark Sloan, MD, David C Seldin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3463.
https://doi.org/10.1182/blood.V124.21.3463.3463
Published: 2014
Journal Articles

Effect of Severe Hypoalbuminemia on Myelosuppression and Other Toxicities of High Dose Melphalan and Autologous Stem Cell Transplantation in AL Amyloidosis Patients

Robert Meehan, MD, David Seldin, MD, John Mark Sloan, MD, Karen Quillen, MD MPH, Dina Brauneis, ANP, Anthony C Shelton, RN, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2014) 124 (21): 5906.
https://doi.org/10.1182/blood.V124.21.5906.5906
Published: 2014
Journal Articles

Long-Term Outcome Of Patients With AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell Transplantation: 19 Year Experience At a Single Center

Vaishali Sanchorawala, MD, Gheorghe Doros, Karen Quillen, MD, MPH, John Mark Sloan, MD, Anthony C Shelton, RN, Dina Brauneis, ANP, Kathleen T Finn, ANP, David C Seldin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3328.
https://doi.org/10.1182/blood.V122.21.3328.3328
Published: 2013
Journal Articles

Risk of Second Primary Malignancies in Patients with AL Amyloidosis Treated with Lenalidomide

Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Gheorghe Doros, PhD, David C Seldin, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1873.
https://doi.org/10.1182/blood.V120.21.1873.1873
Published: 2012
Journal Articles

Treatment of AL Amyloidosis with Two Cycles of Induction Therapy with Bortezomib and Dexamethasone Followed by Bortezomib-High Dose Melphalan Conditioning and Autologous Stem Cell Transplantation

Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Dina Brauneis, ANP, Karen Quillen, MD, MPH, Nancy T Andrea, MD, John Mark Sloan, MD, David C Seldin, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2019.
https://doi.org/10.1182/blood.V120.21.2019.2019
Published: 2012
Journal Articles

Lenalidomide and Dexamethasone in the Treatment of AL Amyloidosis: Final Results of A Phase II Trial

Divya Nair, MD, Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Salli A Fennessey, Kathleen T Finn, ANP, Martha Skinner, MD, Jerome B. Zeldis, MD, PhD, David C Seldin, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4084.
https://doi.org/10.1182/blood.V120.21.4084.4084
Published: 2012
Journal Articles

Melphalan, Lenalidomide and Dexamethasone Combination Therapy In Patients with AL Amyloidosis

Jaymin Patel, MD, John Mark Sloan, MD, Anthony C Shelton, RN, Kathleen T Finn, ANP, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2011) 118 (21): 2924.
https://doi.org/10.1182/blood.V118.21.2924.2924
Published: 2011
Journal Articles

Increases In B-Type Natriuretic Peptide (BNP) During Treatment with Lenalidomide In AL Amyloidosis

Umit Tapan, MD, David C Seldin, MD, PhD, Kathleen T Finn, ANP, Salli Fennessey, CRA, Anthony C Shelton, RN, Jerome B. Zeldis, MD, PhD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2010) 116 (21): 3021.
https://doi.org/10.1182/blood.V116.21.3021.3021
Published: 2010
Journal Articles

Lenalidomide Treatment In Patients with AL Amyloidosis Associated End-Stage Renal Disease and Dialysis

Vaishali Sanchorawala, MD, Kathleen T Finn, ANP, Salli Fennessey, CRA, Anthony C Shelton, RN, Jerome B. Zeldis, MD, PhD, David C Seldin, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3022.
https://doi.org/10.1182/blood.V116.21.3022.3022
Published: 2010